Seeing Is Believing
Reneo Pharmaceuticals's activity chart (see below) currently has 15 price targets and 17 ratings on display.
Analysts average stock forecasts to be materialized ratio is 78.94% with an average time for these price targets to be met of 132.82 days.
Most recent stock forecast was given by MITCHELL KAPOOR from HC WAINWRIGHT on 14-May-2024. First documented stock forecast 04-May-2021.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 14-May-2024
$30
2 years 5 months 17 days ago
(14-May-2024)
3/5 (60%)
$15.8 (111.27%)
64
Buy Since 24-Mar-2022
$10
$8.18 (449.45%)
$15
2 years 10 months 16 days ago
(15-Dec-2023)
2/2 (100%)
$-4.2 (-29.58%)
460
Hold Since 15-Dec-2023
$18
$16.18 (889.01%)
$240
2 years 10 months 16 days ago
(15-Dec-2023)
1/2 (50%)
$3.8 (26.76%)
145
Buy Since 04-May-2021
$4
$2.18 (119.78%)
$25
2 years 10 months 17 days ago
(14-Dec-2023)
5/6 (83.33%)
$-9.4 (-70.15%)
163
Buy Since 19-Sep-2022
$30
$28.18 (1548.35%)
$30
3 years 1 months 23 days ago
(08-Sep-2023)
3/3 (100%)
$-41.1 (-57.81%)
71
What is RPHM (Reneo Pharmaceuticals) average time for price targets to be met?
Which analyst most recently updated their price target on RPHM (Reneo Pharmaceuticals)?
Which analyst has the most public recommendations on RPHM (Reneo Pharmaceuticals)?
Which analyst is the currently most bullish on RPHM (Reneo Pharmaceuticals)?
Which analyst is the currently most reserved on RPHM (Reneo Pharmaceuticals)?